IgAN is a type of rare kidney disease that is caused when there is buildup of antibodies in the kidneys and can lead to kidney damage over time. Despite the seriousness of this disease, there is still significant unmet need for people living with IgAN. Our aim is to bring options to people that help address a range of rare kidney diseases. See how we're working to advance research: ow.ly/PCxx50X0lTM | Biogen
0:37
IgAN is a type of rare kidney disease that is caused when there is build…
304 views7 months ago
FacebookBiogen
For adults with IgA nephropathy, discover how others manage IgAN. For additional Important Safety Information, including serious side effects, please see the Medication Guide at bit.ly/FILSPARI-med-guide. | FILSPARI® (sparsentan)
3:40
For adults with IgA nephropathy, discover how others manage IgAN…
1.5M views7 months ago
FacebookFILSPARI® (sparsentan)
IgAN Management Into Practice: Evolving Guidelines & Targeted Therapies
13:36
IgAN Management Into Practice: Evolving Guidelines & Targeted T…
5 months ago
reachmd.com
Biogen lance un essai de phase 3 pour le felzartamab dans une maladie rénale rare
Biogen lance un essai de phase 3 pour le felzartamab dans une mala…
10 months ago
zonebourse.com
We are studying IgA nephropathy (IgAN), a serious autoimmune kidney disease that results from uncontrolled B cells. Our investigational approach aims to address the root cause of IgAN. Learn more about our strategy in IgAN and other conditions: https://www.vrtx.com/our-science/vertex-forward/#igan | Vertex
2:58
We are studying IgA nephropathy (IgAN), a serious autoimmune kid…
122 views2 months ago
FacebookVertex
Antibody-mediated rejection is a leading cause of kidney transplant failure. Felzartamab, an IgG1 monoclonal CD38 antibody, is under study for treating antibody-mediated rejection. Research findings are summarized in a new Quick Take video. https://nej.md/4dHQhsa | The New England Journal of Medicine
2:07
Antibody-mediated rejection is a leading cause of kidney transplan…
1.4K viewsJul 14, 2024
FacebookThe New England Journal of Medicine
Biogen Inc.: Biogen Initiates Phase 3 Study of Felzartamab for the Treatment of Primary Membranous Nephropathy
Biogen Inc.: Biogen Initiates Phase 3 Study of Felzartamab for the Tre…
10 months ago
finanznachrichten.de
Biogen lance une étude de phase 3 sur le Felzartamab pour le traitem…
Mar 11, 2025
zonebourse.com
2:22
𝗜𝗦𝗡 𝗩𝗜𝗗𝗘𝗢 𝗔𝗕𝗦𝗧𝗥𝗔𝗖𝗧 𝗦𝗘𝗥𝗜𝗘𝗦: Randomized, Double-Blind, Placebo-Controlled Phase 2a Stud…
289 views3 months ago
FacebookThe International Society of Nephrology (ISN)
8:01
Emerging Evidence: IgAN Disease-Modifying Agents
2 views1 week ago
YouTubeReachMD
7:39
IgAN: Making Sense of New Treatments and Guidelines
157 views3 weeks ago
YouTubeGlomCon Foundation
2:54
Trending in Oncology: Ifinatamab Priority Review and more
1 week ago
YouTubeLucidQuest
2:31
Challenging Common Misconceptions About IgAN
3 views5 months ago
YouTubeReachMD
Izalontamab Brengitecan Shows Promising Results in NSCLC with …
1 views2 months ago
linkedin.com
17:05
Interferon Gamma Release Assays (IGRAs)
52.3K viewsNov 1, 2019
YouTubeAssociation for Diagnostics & Laboratory Medici…
41:32
Advancements in IgA Nephropathy
2.4K viewsMar 3, 2025
YouTubePeerView CME
19:45
The IgAN Treatment Pipeline: Complement Pathway
14K viewsFeb 6, 2025
YouTubeNational Kidney Foundation
17:39
The IgAN Treatment Pipeline: Pathogenesis Review
13.7K viewsFeb 6, 2025
YouTubeNational Kidney Foundation
14:52
The IgAN Treatment Pipeline: B-cell Pathway
3.1K viewsFeb 6, 2025
YouTubeNational Kidney Foundation
21:59
The IgAN Treatment Pipeline: Current Treatment Landscape
11.3K viewsFeb 6, 2025
YouTubeNational Kidney Foundation
1:29
Novel promising agents for the treatment of ITP
8.1K viewsJan 19, 2023
YouTubeVJHemOnc – Video Journal of Hematology & H…
2:44
SGLT2 Inhibitors Explained in 3 Minutes
47.3K viewsJan 6, 2019
YouTubeDrug Matters
3:53
Proteasome inhibitor drugs
26.1K viewsApr 4, 2017
YouTubeMyeloma UK
9:45
Felzartamab Enters Phase 3 Trial for PMN
255 views9 months ago
YouTubeNephrology Times
24:19
Are Steroids [Almost] Over? MYOSTATIN INHIBITORS Will Cha…
157.7K views10 months ago
YouTubeDr. Alex Tatem
8:31
Insights into the IgAN Patient Journey: From Diagnosis to Treat…
20 views5 months ago
YouTubeReachMD
1:00:37
Episode 2 - IgAN & FSGS Series: Management, Treatment & Recom…
2.9K viewsJul 22, 2022
YouTubeKDIGO
0:39
A Breakthrough in IgA #Nephropathy: A Treatment that L…
770 views4 months ago
YouTubeHCPLive
9:10
Doctor PREDICTS Future Muscle Drugs: Bimagrumab, Follistatin, O…
25.7K views3 months ago
YouTubeDr. Alex Tatem
0:09
Breakthrough Therapy: Izalontamab for EGFR-Mutated Lung Cancer | …
181 views8 months ago
YouTubeMCQ Pedia
See more videos
Static thumbnail place holder